Eli Lilly and Company will invest more than $1 billion over the next several years into new contract manufacturing in India. Additionally, the global pharma major will establish a new manufacturing and quality facility in Hyderabad.
The investment will further strengthen the manufacturing and supply capabilities to support the company’s evolving portfolio, Eli Lilly said on Monday (October 6, 2025).
Continue Reading on The Hindu
This preview shows approximately 15% of the article. Read the full story on the publisher's website to support quality journalism.